Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Estimating the Effectiveness of Rotavirus Vaccine Schedules.

Publication ,  Journal Article
Butler, AM; Breskin, A; Sahrmann, JM; Brookhart, MA
Published in: Epidemiology
July 1, 2021

BACKGROUND: Important questions exist regarding the comparative effectiveness of alternative childhood vaccine schedules; however, optimal approaches to studying this complex issue are unclear. METHODS: We applied methods for studying dynamic treatment regimens to estimate the comparative effectiveness of different rotavirus vaccine (RV) schedules for preventing acute gastroenteritis-related emergency department (ED) visits or hospitalization. We studied the effectiveness of six separate protocols: one- and two-dose monovalent rotavirus vaccine (RV1); one-, two-, and three-dose pentavalent rotavirus vaccine (RV5); and no RV vaccine. We used data on all infants to estimate the counterfactual cumulative risk for each protocol. Infants were censored when vaccine receipt deviated from the protocol. Inverse probability of censoring-weighted estimation addressed potentially informative censoring by protocol deviations. A nonparametric group-based bootstrap procedure provided statistical inference. RESULTS: The method yielded similar 2-year effectiveness estimates for the full-series protocols; weighted risk difference estimates comparing unvaccinated children to those adherent to either full-series (two-dose RV1, three-dose RV5) corresponded to four fewer hospitalizations and 12 fewer ED visits over the 2-year period per 1,000 children. We observed dose-response relationships, such that additional doses further reduced risk of acute gastroenteritis. Under a theoretical intervention to fully vaccinate all children, the 2-year risk differences comparing full to observed adherence were 0.04% (95% CI = 0.03%, 0.05%) for hospitalizations and 0.17% (95% CI = 0.14%, 0.19%) for ED visits. CONCLUSIONS: The proposed approach can generate important evidence about the consequences of delaying or skipping vaccine doses, and the impact of interventions to improve vaccine schedule adherence.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Epidemiology

DOI

EISSN

1531-5487

Publication Date

July 1, 2021

Volume

32

Issue

4

Start / End Page

598 / 606

Location

United States

Related Subject Headings

  • Vaccines, Attenuated
  • Rotavirus Vaccines
  • Rotavirus Infections
  • Rotavirus
  • Infant
  • Humans
  • Hospitalization
  • Gastroenteritis
  • Epidemiology
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Butler, A. M., Breskin, A., Sahrmann, J. M., & Brookhart, M. A. (2021). Estimating the Effectiveness of Rotavirus Vaccine Schedules. Epidemiology, 32(4), 598–606. https://doi.org/10.1097/EDE.0000000000001363
Butler, Anne M., Alexander Breskin, John M. Sahrmann, and M Alan Brookhart. “Estimating the Effectiveness of Rotavirus Vaccine Schedules.Epidemiology 32, no. 4 (July 1, 2021): 598–606. https://doi.org/10.1097/EDE.0000000000001363.
Butler AM, Breskin A, Sahrmann JM, Brookhart MA. Estimating the Effectiveness of Rotavirus Vaccine Schedules. Epidemiology. 2021 Jul 1;32(4):598–606.
Butler, Anne M., et al. “Estimating the Effectiveness of Rotavirus Vaccine Schedules.Epidemiology, vol. 32, no. 4, July 2021, pp. 598–606. Pubmed, doi:10.1097/EDE.0000000000001363.
Butler AM, Breskin A, Sahrmann JM, Brookhart MA. Estimating the Effectiveness of Rotavirus Vaccine Schedules. Epidemiology. 2021 Jul 1;32(4):598–606.

Published In

Epidemiology

DOI

EISSN

1531-5487

Publication Date

July 1, 2021

Volume

32

Issue

4

Start / End Page

598 / 606

Location

United States

Related Subject Headings

  • Vaccines, Attenuated
  • Rotavirus Vaccines
  • Rotavirus Infections
  • Rotavirus
  • Infant
  • Humans
  • Hospitalization
  • Gastroenteritis
  • Epidemiology
  • Child